KLEMP WALTER V 4
4 · Moleculin Biotech, Inc. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
KLEMP WALTER V
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2025-11-04$0.50/sh−7,001$3,479→ 765,356 total - Exercise/Conversion
Common Stock
2025-11-04+28,750→ 772,357 total - Exercise/Conversion
Restricted Stock Units
2025-11-04−28,750→ 2,380,731 total→ Common Stock (28,750 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- [F3]On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.